A Discussion on Second Wave of COVID-19 Pandemic in India

Abstract

In India, a new double mutant strain of the SARS-CoV-2 virus has been discovered. The new virus strain, which contains two mutations, is highly infectious and has the ability to bypass immunity acquired by natural infection or vaccination. The development raises significant concerns for the nation, as a second wave of the COVID-19 pandemic looms large in a country where over 50 million people have already been vaccinated against the disease. The fraction of samples with the E484Q and L452R mutations has increased in Maharashtra, India, compared to December 2020, according to an examination of samples from the state. India has administered more than 100 million doses of the COVID-19 vaccine as of April 10, making it the fastest country to do so. The vaccine can now be administered in private sector facilities as well. This necessitates a high degree of planning and readiness at each centre.